Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
14.42
-0.31 (-2.10%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Jade Biosciences Market Cap
Jade Biosciences has a market cap or net worth of $917.07 million as of September 25, 2026. Its market cap has increased by 246.16% in one year.
Market Cap
917.07M
Enterprise Value
457.26M
1-Year Change
246.16%
Ranking
Category
Stock Price
$14.42
ChartMarket Cap Chart
Since April 29, 2025, Jade Biosciences's market cap has increased from $326.87M to $917.07M, an increase of 180.56%. That is a compound annual growth rate of 108.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 917.07M | 29.19% |
| Dec 31, 2025 | 709.84M | 117.16% |
| Apr 29, 2025 | 326.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Corvus Pharmaceuticals | 1.13B |
| MannKind | 1.12B |
| Odyssey Therapeutics | 1.12B |
| Monte Rosa Therapeutics | 1.07B |
| Adlai Nortye Group | 1.07B |
| Janux Therapeutics | 1.07B |
| Apnimed | 1.06B |
| Obsidian Therapeutics | 1.05B |